1 of 1
Story summary
- Danone reported fourth-quarter sales growth above expectations driven by protein-rich products.
- A recall of baby formula linked to contamination could shave up to €70 million from next quarter sales.
- Danone's CEO stressed the need to improve performance in the U.S. market despite growth in Asia.
- Danone plans to launch new high-protein products to capture opportunities.
- Its stock has declined this year.
